• Suggestions to Make Health Technology Assessment in India an Efficient Process

    May 1, 2021, 00:00

  • Health Technology Assessment in Australia: The Pharmaceutical Benefits Advisory Committee and Medical Services Advisory Committee

    May 1, 2021, 00:00

  • Addressing Challenges in Health Technology Assessment Institutionalization for Furtherance of Universal Health Coverage Through South-South Knowledge Exchange: Lessons From Bhutan, Kenya, Thailand, and Zambia [Editor's Choice]

    May 1, 2021, 00:00

  • Similarities and Differences in Health-Related Quality-of-Life Concepts Between the East and the West: A Qualitative Analysis of the Content of Health-Related Quality-of-Life Measures

    May 1, 2021, 00:00

  • Socioeconomic Impact of Hospitalization Expenditure for Treatment of Noncommunicable Diseases in India: A Repeated Cross-Sectional Analysis of National Sample Survey Data, 2004 to 2018

    May 1, 2021, 00:00

  • A Study Comparing Cost-Effectiveness of Combination Therapy for Preventing Opportunistic Infections Among Human Immunodeficiency Virus–Infected Adults on Antiretroviral Therapy

    May 1, 2021, 00:00

  • Mapping Utility Scores From the HeartQoL Questionnaire Into the EQ-5D for Ischemic Heart Disease

    May 1, 2021, 00:00

  • Current Development and Practice of Pharmacoeconomic Evaluation Guidelines for Universal Health Coverage in China

    May 1, 2021, 00:00

  • A Cost-Effectiveness Analysis of Neuraminidase Inhibitors for Influenza Virus Infections in an Adult-Outpatient Setting in Japan

    May 1, 2021, 00:00

  • Cost-Effectiveness of Mirogabalin for the Treatment of Diabetic Peripheral Neuropathic Pain in Taiwan

    May 1, 2021, 00:00

  • Using Contingent Valuation Method to Estimate Adults’ Willingness to Pay for a Future Coronavirus 2019 Vaccination

    May 1, 2021, 00:00

  • Is It Worth Delaying Total Knee Replacement as Late as Possible? A Cost-Effectiveness Analysis Using a Markov Model in the Indian Setting

    May 1, 2021, 00:00

  • Coronavirus Disease 2019 in 5 Neighboring Limited-Resource Countries: A Financial and Health Threat

    May 1, 2021, 00:00

  • Cost-Effective Analysis of the Congenital Hypothyroidism Screening Program in Sri Lanka

    May 1, 2021, 00:00

  • Current Status of Research on the Mapping Function of Health Utility Values in the Asia Pacific Region: A Systematic Review [Editor's Choice]

    May 1, 2021, 00:00

  • Health-Related Quality of Life Among Children With Pneumonia in Indonesia Using the EuroQoL Descriptive System Value Set for Indonesia

    May 1, 2021, 00:00

  • Predictors of Health-Related Quality-of-Life Status Among Elderly Patients With Cardiovascular Diseases

    May 1, 2021, 00:00

  • Economic Viability and Efficacy of Day Case Versus Inpatient Tonsillectomy in Southern Iran

    May 1, 2021, 00:00

  • Cost-Effectiveness of Lenvatinib in the Treatment of Patients With Unresectable Hepatocellular Carcinomas in Japan: An Analysis Using Data From Japanese Patients in the REFLECT Trial

    May 1, 2021, 00:00

  • Validity of the Malay EQ-5D-3L in the Malaysian Transfusion-Dependent Thalassemia Population

    May 1, 2021, 00:00

  • Patient Journey and Disease-Related Burden in Japanese Patients With Chronic Thromboembolic Pulmonary Hypertension: A Mixed Methods Study [Editor's Choice]

    May 1, 2021, 00:00

  • Mapping QLQ-C30 Onto EQ-5D-5L and SF-6D-V2 in Patients With Colorectal and Breast Cancer From a Developing Country

    May 1, 2021, 00:00

  • Development and Validation of a Chronic Kidney Disease Prediction Model for Type 2 Diabetes Mellitus in Thailand

    May 1, 2021, 00:00

  • Cost-Effectiveness of Juluca for Human Immunodeficiency Virus Infection Treatment in Virologically Suppressed Adults in Taiwan [Editor's Choice]

    May 1, 2021, 00:00

  • Reviewer Acknowledgment

    Dec 16, 2020, 17:31

  • Copyright/Subscription

    Dec 9, 2020, 11:53

  • Treatment Satisfaction Questionnaire for Medication (TSQM version 1.4): Ceiling and Floor Effects, Reliability, and Known-Group Validity in Brazilian Outpatients With Hypertension

    Dec 1, 2020, 00:00

  • Omitted Conflict of Interest Disclosures in Previously Published Articles

    Dec 1, 2020, 00:00

  • Cost-Effectiveness of Natalizumab Compared With Fingolimod for Relapsing-Remitting Multiple Sclerosis Treatment in Colombia

    Dec 1, 2020, 00:00

  • Editorial Board

    Dec 1, 2020, 00:00

  • Satisfaction With Healthcare Services Among Patients With Diabetes, Hypertension, and/or Dyslipidemia in Mexico: A Cross-Sectional Study

    Dec 1, 2020, 00:00

  • Willingness of Infertile Couples to Pay for In Vitro Fertilization Treatment in the Integrated Human Reproduction Section of the Escola Paulista de Medicina, São Paulo Federal University

    Dec 1, 2020, 00:00

  • 24/7 Physical Therapy Intervention With Adult Patients in a Chilean Intensive Care Unit: A Cost-Benefit Analysis in a Developing Country

    Dec 1, 2020, 00:00

  • International Experience in Therapeutic Value and Value-Based Pricing: A Rapid Review of the Literature

    Dec 1, 2020, 00:00

  • Is There Something Else Beyond Cost-Effectiveness Analysis for Public Health Decision Making?

    Dec 1, 2020, 00:00

  • Cost-Effectiveness Analysis and Budget Impact: Antimuscarinics and Mirabegron for the Treatment of Patients With Urge Urinary Incontinence: The Brazilian Public Health System Perspective

    Dec 1, 2020, 00:00

  • Cost Analysis of Cancer in Brazil: A Population-Based Study of Patients Treated by Public Health System From 2001-2015 (Editor's Choice)

    Dec 1, 2020, 00:00

  • Limitations and Challenges of Conducting Budget Impact Analyses in Rare Diseases: A Case Study of Alpha-1 Antitrypsin Deficiency (Editor's Choice)

    Dec 1, 2020, 00:00

  • Cost-Effectiveness of the Addition of Bevacizumab to First-Line Chemotherapy With Carboplatin and Paclitaxel in Patients With Non–Small Cell Lung Cancer

    Dec 1, 2020, 00:00

  • Cost-Effectiveness Analysis of Rehabilitation Interventions for Teeth With Extensive Coronary Destruction

    Dec 1, 2020, 00:00

  • Treatment With Liposomal Amphotericin B for All Confirmed Cases of Human Visceral Leishmaniasis in Brazil: A Budget Impact Analysis

    Dec 1, 2020, 00:00

  • Adaptation and Validation of the Health Belief Model Scale for Breast Self-Examination in Mexican Women

    Dec 1, 2020, 00:00

  • Costs Associated With Early Vascular and Biliary Complications in Liver-Transplanted Patients in a Hospital in Antioquia, Colombia 2019: A Case Series

    Dec 1, 2020, 00:00

  • Cost-Effectiveness Analysis of Point-of-Care Rapid Testing Versus Laboratory-Based Testing for Antenatal Screening of Syphilis in Brazil

    Dec 1, 2020, 00:00

  • Cost and Effectiveness of the Treatment of Chronic Hepatitis C in Brazil: Real-World Data (Editor's Choice)

    Dec 1, 2020, 00:00

  • Implementing Health Technology Assessments in Latin America: Looking at the Past, Mirroring the Future. A Perspective from the ISPOR Health Technology Assessment Roundtable in Latin America (Editor's Choice)

    Dec 1, 2020, 00:00

  • What Do Doctors Think About Value-Based Healthcare? A Survey of Practicing Physicians in a Private Healthcare Provider in Brazil (Editor's Choice)

    Dec 1, 2020, 00:00

  • Table of Contents

    Dec 1, 2020, 00:00

  • How Educational Inequalities in Cardiovascular Mortality Evolve While Healthcare Insurance Coverage Grows: Colombia, 1998 to 2015

    Dec 1, 2020, 00:00

  • Multi-Criteria Model for Evaluating Drugs to Prevent Deep Venous Thrombosis Associated With Orthopedic Surgery: A Hospital-Based Case Study

    Dec 1, 2020, 00:00

  • Copyright/Subscription

    Sep 12, 2020, 10:30

  • PCV8 Cost-Utility and Budget IMPACT Analysis of Using Ranolazine in the Treatment of Refractory Stable Angina, an Iranian Heath System Perspective

    Sep 1, 2020, 00:00

  • PRO6 Epidemiology and Treatment Patterns of Hemophilia a in Taiwan from 2013 to 2017

    Sep 1, 2020, 00:00

  • PND29 Children with Hyperactive-Impulsive Disorder Benefit from Yoga Exercises

    Sep 1, 2020, 00:00

  • PCN36 Cost-Effectiveness Analysis of Pembrolizumab Versus Nivolumab As the First-LINE Treatment for Advanced and Metastatic NON-SMALL CELL LUNG Cancer in Germany

    Sep 1, 2020, 00:00

  • PDB8 Short-TERM Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Insulin Degludec in Patients with Type 2 Diabetes in China

    Sep 1, 2020, 00:00

  • PIN54 Association of Maternal Hbsag and Hbeag Serostatus and Congenital Abnormalities Following Assisted Reproduction: A Population-Based Study

    Sep 1, 2020, 00:00

  • PCN49 Disease Burden of Classical Hodgkin Lymphoma UNDER Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PNS49 Building Capacity for HTA in the Philippines: An Imperative UNDER UHC

    Sep 1, 2020, 00:00

  • PNS18 UNDER Threat of Covid-19, Is IT Against Humanitarianism to Adopt Sealed Management in Public Health Emergencies? a Survey Based on Chinese Public Attitudes Towards the Lockdown of Wuhan, China

    Sep 1, 2020, 00:00

  • PIN33 Public Health Behaviour Changes during the Covid-19 Outbreak in China: A Comparison in Different Risk Groups

    Sep 1, 2020, 00:00

  • Disclosure Information

    Sep 1, 2020, 00:00

  • PNS27 Diffusion of Pharmaceutical Innovations in the Public Healthcare Setting in Malaysia

    Sep 1, 2020, 00:00

  • PCN98 Assessment of Quality of Life in Patients with Metastatic Breast Cancer and Its Pharmaceutical Management in Tertiary Care Hospital: A Prospective Observational Study

    Sep 1, 2020, 00:00

  • PND28 Children with Hypoxic-Ischaemic Encephalopathy Have a Delay in the Development of Executive Abilities

    Sep 1, 2020, 00:00

  • PGI7 Cost-Effectiveness Analysis of Vonoprazan Versus Proton Pump Inhibitors in the Treatment of Reflux Esophagitis in China

    Sep 1, 2020, 00:00

  • PRS1 Comparison of Clinical Outcomes Associated with Different Inhaler Devices in Asthma and COPD

    Sep 1, 2020, 00:00

  • PNS60 Use of Artificial Intelligence with Distillersr Software in Selected Systematic Literature Reviews

    Sep 1, 2020, 00:00

  • PCN7 Adverse Events (AES) of Advanced Renal CELL Carcinoma (RCC) Patients Treated with Targeted Therapies in Real World Setting in Korea

    Sep 1, 2020, 00:00

  • PNS70 EQ-5D-5L in China and JAPAN: Population Norms and Comparison between the Countries

    Sep 1, 2020, 00:00

  • PSU8 Health Economic Evaluation of Protocol Change Including IV Iron Ferric Carboxymaltose Versus Control Group for HIP Surgery Patients with Iron Deficiency Anemia (IDA) in Korea

    Sep 1, 2020, 00:00

  • PIN34 Effects of Meteorological Factors on the Daily Domestic New CASES of Coronavirus Disease (COVID-19) in Asian Countries: A MULTI-Country Generalized Additive Modeling Analysis

    Sep 1, 2020, 00:00

  • PCN25 Hospital Costs Associated with Powered and Manual Staplers in VIDEO-Assisted Thoracic Surgery Lobectomy for LUNG Cancer in a Chinese Teritary Care Hospital

    Sep 1, 2020, 00:00

  • PMU1 Dancing with the Dragon: Considerations and Learnings in the 2019 China National Reimbursement Drug LIST Negotiations

    Sep 1, 2020, 00:00

  • PRO5 IMPACT of Prophylaxis Costs in a Pediatric Patient Diagnosed with Severe Hemophilia a with Inhibitors in Guayaquil, Ecuador

    Sep 1, 2020, 00:00

  • PCN44 Disease Burden of Follicular Lymphoma UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PIN40 Influenza Vaccination in Adult Patients with Hypertension or Diabetes in South Korea: A CROSS-Sectional Study

    Sep 1, 2020, 00:00

  • PIN45 Comparison of Antibiotics Policies between European Union Countries and JAPAN

    Sep 1, 2020, 00:00

  • PIN37 Projection of Covid-19 Based on Decision Tree Analysis: WE Have NOT Won but WE Have NOT Lost the WAR!

    Sep 1, 2020, 00:00

  • PMU20 Is There an Implicit Willingness-to-Pay Threshold in Singapore?

    Sep 1, 2020, 00:00

  • PDB17 Time to Onset Analysis of Ipilimumab Associated Hypophysitis Using DATA from FDA Adverse Event Reporting System (FAERS) Database

    Sep 1, 2020, 00:00

  • Table of Contents

    Sep 1, 2020, 00:00

  • PCV1 Cardiac Rehabilitation Program in a Tertiary Hospital in Peninsular Malaysia: Outcome and Associations

    Sep 1, 2020, 00:00

  • PCN29 Diagnosing and Classifying ACUTE Leukemia Patients through Immunophenotyping By FLOW Cytometry in Indonesia

    Sep 1, 2020, 00:00

  • PDB25 Long-Term Drug Survival and Low Remission Rates in Dyslipidemia Patients Having Drug Safety Concerned and Safety Literacy

    Sep 1, 2020, 00:00

  • PCN38 Cost-Effectiveness of Mammography As a Screening Test for EARLY Detection of Breast Cancer

    Sep 1, 2020, 00:00

  • PMS6 Incidence and Prevalence of Osteoporosis and Related Fractures in ASIA and the Pacific: A Systematic Review

    Sep 1, 2020, 00:00

  • PCV2 Volatile Anesthetics Versus TOTAL Intravenous Anesthesia in Patients Undergoing Coronary Artery Bypass Grafting: An Updated Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials

    Sep 1, 2020, 00:00

  • PIH11 Falls Risk Increasing Drugs in the Elderly: Population Based Study Using Korean National Health Insurance Claims Database

    Sep 1, 2020, 00:00

  • PMU8 The Increasing Burden of NON-Communicable Diseases in India

    Sep 1, 2020, 00:00

  • PCV13 Health Economic Evaluation of Screening and Treating Children with Familial Hypercholesterolemia EARLY in Life: Many Happy Returns on Investment?

    Sep 1, 2020, 00:00

  • PIH17 Efficacy, Tolerability And Medication Adherence Of Twice-Daily Dosing Schedule Of Deferasirox In Transfusion-Dependent Paediatric Beta-Thalassemia Patients: A Randomized Controlled Study

    Sep 1, 2020, 00:00

  • PBI2 Economic Evaluation of GENE Therapies: IMPACT of Alternative Payment Models on Uncertainty Around the Icer

    Sep 1, 2020, 00:00

  • PDG17 The Economic IMPACT Analysis of a Proposal to Abandon NON-Prescription Drug Reimbursement in Thailand, a Case Study of NON-Sedating Antihistamines

    Sep 1, 2020, 00:00

  • Cefuroxime (Aprokam®) in the Prophylaxis of Postoperative Endophthalmitis After Cataract Surgery Versus Absence of Antibiotic Prophylaxis: A Cost-Effectiveness Analysis in Poland

    Sep 1, 2020, 00:00

  • PIN2 Heterogeneity in Association of Use of Direct Acting Antivirals with Mortality Among Patients with Hepatitis C in the United States

    Sep 1, 2020, 00:00

  • PSU6 A Patient-LEVEL Simulation for Economic Evaluation of Vascular Service Reconfiguration in England

    Sep 1, 2020, 00:00

  • PNS53 Differences in Evidence Reviews Requirements for Health Technology Assessment (HTA) Document Development between Selected Countries

    Sep 1, 2020, 00:00

  • PNS42 Health Care Professionals and Mobile Applications: A Systematic Review

    Sep 1, 2020, 00:00

  • PCN32 Cost Analysis of Chronic Myeloid Leukemia Patients Using Tyrosine Kinase Inhibitor in Vietnam

    Sep 1, 2020, 00:00

  • PNS63 A Cross-Sectional Study About Medications Wastage In Saudi Arabia

    Sep 1, 2020, 00:00

  • PCV7 Budget IMPACT Analysis on Fufang Xueshuantong Capsule in Treating Stable Angina Pectoris in China

    Sep 1, 2020, 00:00

  • PMU28 Utilization Patterns of a Japanese Biomedical Database, Ichushi, in Real-World Evidence Review: A Scoping Review

    Sep 1, 2020, 00:00

  • PCN66 Utilization of EGFR and ALK Testing in LUNG Cancer Patients Using Real Wrold DATA from China

    Sep 1, 2020, 00:00

  • PIN51 Out-of-Pocket Healthcare Expenditure in Various Household Income Groups Among Patients with Hepatitis C Disease Stages: Findings from a Tertiary Care Centre in Malaysia

    Sep 1, 2020, 00:00

  • PNS1 Real-World DATA Collection in China: Challenges and Recommendations to Ensure DATA Quality

    Sep 1, 2020, 00:00

  • PNS58 The Efficiency Analysis of 19 Medical Centers in Taiwan

    Sep 1, 2020, 00:00

  • PDB27 Association between Health Characteristics and Mode of Insulin Administration Among Patients with Type II Diabetes in 2017 China National Health and Wellness Survey

    Sep 1, 2020, 00:00

  • PDB19 Estimating National Burden of Disease Due to Type 2 Diabetes Considering Complications in Korea

    Sep 1, 2020, 00:00

  • PND30 Breathing Training HAS Positive Effect on Attention in Children with ADHD

    Sep 1, 2020, 00:00

  • PDG15 Dollars DRIVE Decisions: TOTAL Healthcare Spending Best Predicts Country Selection for New Drug Launches

    Sep 1, 2020, 00:00

  • PCN15 Disease Burden of Myelodysplastic Syndrome UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PRO16 Healthcare Resource Utilization (HCRU) in Patients with Generalized Pustular Psoriasis (GPP) in JAPAN: A Claims Database Study

    Sep 1, 2020, 00:00

  • PSU3 Clinical Outcomes and Economics Associated with Surgical Aortic Valve Replacement in Taiwan

    Sep 1, 2020, 00:00

  • PNS17 Experience and Prevalence of Iqos Heated Tobacco Product Among Adolescents in Taiwan

    Sep 1, 2020, 00:00

  • PCN1 IMPACT of PD-1/PD-L1 Inhibitors on Health Outcomes for Patients with Cancer in South Korea

    Sep 1, 2020, 00:00

  • PCN11 The Challenges and Unmet Needs in the Management of Hepatocellular Carcinoma (HCC) Patients and Burden of Advanced HCC across Hong Kong, Singapore and Thailand

    Sep 1, 2020, 00:00

  • PRO17 Healthcare Resource Utilization (HCRU) in Patients with Palmoplantar Pustulosis (PPP) in JAPAN: A Claims Database Study

    Sep 1, 2020, 00:00

  • PDB21 Safety and Efficacy Comparison between Insulin Degludec and Insulin Glargine

    Sep 1, 2020, 00:00

  • PIH1 Development and Validation of a Prediction MODEL on Severe Maternal Outcomes Among Pregnant Women with PRE-Eclampsia: A 10-Year Cohort Study

    Sep 1, 2020, 00:00

  • PMD13 Estimating the Cost of Treating Myasthenia Gravis Patient in a Single Public Hospital

    Sep 1, 2020, 00:00

  • Cost-Minimization Analysis of Ranibizumab Versus Aflibercept for Treating Saudi Patients With Visual Impairment Owing to Age-Related Macular Degeneration or Diabetic Macular Edema

    Sep 1, 2020, 00:00

  • PMD7 Analysis of Medical Device Recall Reports in China from a Regulatory Science Perspective: Implications for Post-Marketing Surveillance

    Sep 1, 2020, 00:00

  • PND23 Treatment Gaps in Deep Brain Stimulation for Patients with Parkinson's Disease: A Comparative Analysis of Nine High-Income Countries

    Sep 1, 2020, 00:00

  • PDB26 Knowledge, Attitude and Practices of Insulin Self-Administration Techniques Among Diabetic Patients

    Sep 1, 2020, 00:00

  • PCN91 Penetration of Artificial Intelligence (AI) and Machine Learning (ML) in the Randomized Controlled Setting of Oncology

    Sep 1, 2020, 00:00

  • PDB4 Study on Standard Criteria of SERUM Uric Acid and Factors of High Uric Acid in Children Using Claims Database in JAPAN

    Sep 1, 2020, 00:00

  • PNS6 Risk Of Bias In Model-Based Economic Evaluations Of Tobacco Control Interventions In Asia: A Systematic Review

    Sep 1, 2020, 00:00

  • PIN16 Disease Burden of Progressive Chronic Hepatitis B in China

    Sep 1, 2020, 00:00

  • PMS7 Osteoporosis Diagnosis and Treatment Among Women in China: A Simulation Projection Model of Clinical and Economic Benefits through 2040

    Sep 1, 2020, 00:00

  • PNS20 Repercussions of Physical Exercises on Physical Health

    Sep 1, 2020, 00:00

  • PMU21 Incorporating Preference Heterogeneity in Public Healthcare Policy Decision-Making: A Scoping Review of the Literature

    Sep 1, 2020, 00:00

  • PDB23 Efficacy and Safety of Teprotumumab in the Treatment of Thyroid Eye Disorder: A Systematic Review and Meta-Analysis

    Sep 1, 2020, 00:00

  • PIN28 Prediction of the PEAK Dates of the Numbers of COVID19 Pandemic Patients

    Sep 1, 2020, 00:00

  • PUK8 Cost-Effectiveness Analysis of Haemodiafiltration (HDF) Versus Haemodialysis (HD) in South Korea

    Sep 1, 2020, 00:00

  • PND6 Drug Utilization of Gastrodin Injection on the Treatment of Dizziness and Vertigo: An Analysis Using Electronic Medical Records in China

    Sep 1, 2020, 00:00

  • PCN72 APAC Overview of the Accelerated Approval Pathways: Applications in LUNG Cancer

    Sep 1, 2020, 00:00

  • PCN46 Disease Burden of Chronic Lymphocytic Leukemia/SMALL Lymphocytic Lymphomaunder Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PNS12 A Study on Disabilities and Health-Related Direct Costs of Former Workers of Erdenet Mining Company

    Sep 1, 2020, 00:00

  • PDG16 Pharmaceutical Expenditure Monitoring for Price-Volume Negotiation in South Korea : Lessons and Improvement Points Learned over 11 YEARS

    Sep 1, 2020, 00:00

  • PMH9 Comparison of Approved Doses of Lemborexant for Insomnia in Placebo-Controlled Trials: A Systematic Review and Network Meta-Analysis

    Sep 1, 2020, 00:00

  • PDG5 Cost- Effectiveness Analysis between Aprepitant and Fosaprepitant in the Prevention of Chemotherapy-Induced Nausea and Vomiting in China

    Sep 1, 2020, 00:00

  • PUK1 Low-Flux Hemodialysis Versus High-Flux Hemodialysis for END-STAGE Kidney Disease Meta Analysis

    Sep 1, 2020, 00:00

  • PCV24 Health Technology Assessment Submissions for Cardiovascular Interventions in the ASIA-Pacific Region

    Sep 1, 2020, 00:00

  • PDB30 Digital Medication Health Service Platforms of Pharmaceutical Companies for Type 2 Diabetes Mellitus (T2DM) Patients: A Content Analysis of Application

    Sep 1, 2020, 00:00

  • PIN3 Is Dolutegravir Cost Effective in Treating Patients Living with HIV?

    Sep 1, 2020, 00:00

  • PIN6 Rational Antibiotic Use in Outpatients with UPPER Respiratory TRACT Infections at District Health Promotion Hospital Panasnikom Chonburi

    Sep 1, 2020, 00:00

  • PMU9 Brand-Switching Behavior Following the Implementation of a 63% Tax Increase on Cigarettes in Taiwan

    Sep 1, 2020, 00:00

  • PDB5 Assesment the Quality of Life in Children with Type 1 Diabetes

    Sep 1, 2020, 00:00

  • PCN79 Willingness to Pay for Cancer Screening Testing in Malaysia

    Sep 1, 2020, 00:00

  • Idiopathic Pulmonary Fibrosis: Utilization of Health Services and Out-Of-Pocket Health Expenditures in Greece

    Sep 1, 2020, 00:00

  • PNS16 Health and Economic Burden of Smoking in Indonesia

    Sep 1, 2020, 00:00

  • PCV16 Increasing Burden of Cardiovascular Disease (CVD), the Associated Risk Factors and Drug Utilization Among Smokers in the US: A Study Based on Nhanes from 2005 to 2016

    Sep 1, 2020, 00:00

  • PIN12 Health and Economic IMPACT of 15-Valent Pneumococcal Conjugate Vaccine (V114) Serotypes in Adults 70 YEARS and Older in Australia

    Sep 1, 2020, 00:00

  • PRO7 Economic Burden of Pompe Disease in China: Empirical Evidences and Simulation of Policy Effects

    Sep 1, 2020, 00:00

  • PRO3 Psoriasis As a PROXY for Health-Related Utility Values for Erythrodermic Cutaneous T-CELL Lymphoma

    Sep 1, 2020, 00:00

  • PCN64 Frequency of ORAL Mucositis in Male Patients Receiving Cancer Therapy

    Sep 1, 2020, 00:00

  • PAM6 Cost IMPACT Analysis for Coated VS NON-Coated CVC in China

    Sep 1, 2020, 00:00

  • PCN89 Constructing Comparator Survival DATA: Simulated Versus Individual Patient DATA

    Sep 1, 2020, 00:00

  • PMD1 Effectiveness and Cost Analysis for Peripheral Inserted Central Catheter VS Central Venous Catheter in China

    Sep 1, 2020, 00:00

  • PMU15 Utilization and Spending of Low-VALUE Healthcare UNDER a National Health Insurance Program: A Nationwide Population-Based Study

    Sep 1, 2020, 00:00

  • PNS48 The Analysis of Sources of Utility Values USED in Cost-Utility Analyses in China

    Sep 1, 2020, 00:00

  • PCV26 Quality of Life Improves More for People Who Receive Proactive Absolute Cardiac Risk Management in a Rapid Access Chest Pain Clinic Compared to Usual Care

    Sep 1, 2020, 00:00

  • PMD11 Efficacy of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

    Sep 1, 2020, 00:00

  • PUK3 Cost Consequence Analysis of Remote Monitoring with the Homechoice Claria® with Sharesource® Platform for Automated Peritoneal Dialysis Patients in the Australian Setting

    Sep 1, 2020, 00:00

  • PIN13 Clinicoeconomic IMPACT of an Alcohol Based Hand RUB to Reduce Gram Negative MULTI Drug Resistant Bacteria: A Simulation Study in an Indian Healthcare Setting

    Sep 1, 2020, 00:00

  • PCN85 Comparison of Observed LONG-TERM Overall Survival with Extrapolated Overall Survival for Pembrolizumab Monotherapy Assessed By Australian Reimbursement Authorities

    Sep 1, 2020, 00:00

  • PIN50 Hepatitis B and C: Differences in Diagnosis and Treatment

    Sep 1, 2020, 00:00

  • PCN56 Addressing the Credibility GAP of Real-World Evidence Generation in Southeast ASIA: An Analysis of 200 Articles over 10 YEARS

    Sep 1, 2020, 00:00

  • PMD2 The Relationship between Sedatives and Risk of Ventilator-Associated Events

    Sep 1, 2020, 00:00

  • PNS73 Retrospective Study for Comorbidities in ACTIVE Population Using Japanese Health Insurance Claims Database

    Sep 1, 2020, 00:00

  • PCN95 A Systematic Literature Review of the Use of Mhealth Apps to Improve Quality of Life (QOL) in Cancer Patients

    Sep 1, 2020, 00:00

  • PIN4 Associations between Thromboprophylaxis and Ventilator-Associated Events Among Patients Receiving Mechanically Ventilated

    Sep 1, 2020, 00:00

  • PIH2 Does Fertility Treatment Provide Good VALUE for Money? a Cost-Benefit Analysis

    Sep 1, 2020, 00:00

  • A Contingent Valuation Study for Eliciting a Monetary Value of a Quality-Adjusted Life-Year in the General Greek Population [Editor's Choice]

    Sep 1, 2020, 00:00

  • PDG23 Exploring the Determinants of Pharmaceutical Expenditure Growth: The Case of Cancer Drugs UNDER a Single-Payer System

    Sep 1, 2020, 00:00

  • PMS8 Estimating the Future Clinical and Economic Benefits of Improving Osteoporosis Diagnosis and Treatment Rates Among Women in South Korea: A Simulation Projection Model from 2020-2040

    Sep 1, 2020, 00:00

  • PMD4 Analysis of Costs, Length of Hospital STAY (LOS), Readmission and Quality of Life in Patients Undergoing Primary TOTAL Knee Arthroplasty (TKA) from China ATTUNE® Study

    Sep 1, 2020, 00:00

  • PSU13 The Cost-Effectiveness of I-Factor Compared to Local Autograft in Anterior Cervical Discectomy and Fusion Surgery

    Sep 1, 2020, 00:00

  • PSS1 IMPACT of ITCH on SLEEP in Adults with Atopic Dermatitis: A Targeted Literature Review

    Sep 1, 2020, 00:00

  • PDG1 Prevalence and Determinants of Serious Spontaneously Reported Adverse Drug Events Among Three Outpatient Care Settings in Ghana: Findings and Implications

    Sep 1, 2020, 00:00

  • PND24 Target Identification and Drug Repurposing for Parkinson's Disease: A NOVEL Integrative Computational Approach

    Sep 1, 2020, 00:00

  • PCN68 Real-World Cardiac Safety of Systemic Therapies for HER2+ Metastatic Breast Cancer in Older Versus Younger Patients: A Retrospective Cohort Study Using Electronic Health Record DATA and Cancer Registries

    Sep 1, 2020, 00:00

  • PND11 Pharmacoeconomic Evaluation of Multiple Sclerosis Therapy Costs in Central ASIA

    Sep 1, 2020, 00:00

  • PNS5 Comparison of Instruments Valuing Health-Related Productivity Losses

    Sep 1, 2020, 00:00

  • PIN36 Comparison of Vaccine Market Access Pathways in European and Asian Countries

    Sep 1, 2020, 00:00

  • PIN31 The Epidemiology and Cost of Dengue Disease in Thailand: A Systematic Literature Review

    Sep 1, 2020, 00:00

  • PCN106 Treatment Patterns and Health Resource Utilization in Patients with Hepatocellular Cancer (HCC) Following Failure of Sorafenib in Real World Setting in Taiwan

    Sep 1, 2020, 00:00

  • PCN75 Characterization of Oncology Managed Entry Agreements (MEA) in APAC and Assessment of Payer Considerations

    Sep 1, 2020, 00:00

  • PCN27 Study of Initial Treatment Cost for ACUTE Leukemia Patients in Vietnam

    Sep 1, 2020, 00:00

  • PNS38 Creation of Favorable Conditions for the Development of the Clinical Trials Market

    Sep 1, 2020, 00:00

  • PBI8 The Burden of Health Care Costs for Psoriasis Patients Treated with Biologics in South Korea

    Sep 1, 2020, 00:00

  • PIN21 Cost-Effectiveness of Ceftazidime-Avibactam for Gram-Negative Infections with Limited Treatment Options in China

    Sep 1, 2020, 00:00

  • PRO18 Incidence, Mortality, Hospitalizations, and Expenditures for Pemphigus in Taiwan

    Sep 1, 2020, 00:00

  • PSU10 The IMPACT of Post-Operative Complications on in-Hospital Cost Among 8130 Patients Undergoing Distal Gastrectomy in JAPAN: A Nationwide Registry Study

    Sep 1, 2020, 00:00

  • PCN26 Disease Burden of ACUTE Myelogenous Leukemia UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PCN42 A Real World Comparison of Utility Values Derived from a Discrete Choice Experiment Versus Patient Reported Outcomes in Clinical Trials

    Sep 1, 2020, 00:00

  • PMD10 Cost-Utility Analysis of Robotic-Assisted Surgery for Prostate Cancer Patients in JAPAN

    Sep 1, 2020, 00:00

  • PCN30 Comparison of Health Status Utilities of Breast Cancer with Comorbidities from the Korean National Health and Nutrition Examination Survey (KNHANES) 2008-2018

    Sep 1, 2020, 00:00

  • PIH18 Characterizing the IMPACT of PDE5I Use on the Health and Economic Burden of Erectile Dysfunction in the US, JAPAN, and China

    Sep 1, 2020, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5 (current)
  • 6
  • 7
  • 8
  • 9
  • 10
  • »